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Abstract. 
Lymphoepithelioma-like cholangiocarcinoma (LELCC) is a rare variant of intrahepatic 
cholangiocarcinoma. We herein have reported an unusual case of LELCC in a 71-year-old Tai-
wanese women with cirrhotic liver disease and chronic hepatitis C. The patient’s liver tumor 
was unexpectedly discovered during a regular abdominal ultrasound exam without obvious 
clinical symptoms and signs; she thereafter received surgical resection. Histologically, the liver 
tumor showed lymphoepithelial-like appearance and features of cholangiocarcinoma without 
association with Epstein-Barr virus (EBV). We maintained regular follow-up with the patient 
for 3 years, who at that time was alive without tumor recurrence. 
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中文摘要 
  在肝內膽管癌多種型態中，類淋巴上皮瘤樣膽管癌屬於較罕見的一型。我們在這篇
文章裡報告一位 70 歲女性，有慢性 C 型肝炎與肝硬化，經由手術治療後診斷類淋巴上皮
瘤樣癌管癌的案例。病患在門診規律追蹤，意外發現單一肝腫瘤，影像上懷疑是肝惡性
腫瘤，病患於是接受手術切除。經病理分析，發現此肝腫瘤為類淋巴上皮瘤樣膽管癌。
經免疫染色，發現此類淋巴上皮瘤樣膽管癌與 EB 病毒的感染無關。病患於術後接受規律
追蹤三年，未有腫瘤復發的現象。 
 
關鍵字: 膽管癌、類淋巴上皮瘤樣膽管癌 
 
INTRODUCTION 
Lymphoepithelioma-like cholangiocarcinoma (LE- 
LCC) has been observed to be a rare variant of intra-
hepatic cholangiocarcinoma. Hsu et al. published the 
journal homepage:www.cos.org.tw/web/index.asp
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first case report in 1996 about LELCC and described 
the association between LELCC and EBV [1]. Since 
then, 23 additional cases have been reported. Regard-
ing those cases, some of the tumors were reported to 
be associated with EBV. The association between 
LELCC and EBV is 73.9%, according to a prior case 
report [2]. 
Epstein-Barr virus (EBV), a virus of the herpes 
family, is related to various types of malignancies, 
including nasopharyngeal cancer, Burkitt’s lymphoma, 
and post transplantation lymphoma [3]. Lymphoepi-
thelioma-like carcinomas (LELC) are tumors arising 
from outside the nasopharynx and resemble intense 
lymphocytic infiltrate, and are morphologically like 
undifferentiated nasopharyngeal cancer. LELCs in the 
oral cavity, thymus gland, ovary and stomach have an 
association with EBV. However, cancers arising from 
the skin, cervix and vagina and urinary bladder have 
not had a known association with EBV [2]. 
In this case, we described an unusual case of 
cholangiocarcinoma with lymphoepithelioma-like 
component and the patient was alive without tumor 
recurrence after three years of follow-up. 
 
CASE REPORT 
A 70-year-old Taiwanese female with chronic 
hepatitis C, cirrhotic liver disease post interferon 
treatment and with sustained virological response 
(hepatitis C viral load < 15 IU/mL) was under regular 
clinical follow-up. The patient received routine ab-
dominal ultrasound exams; it was during one of these 
procedures that a liver tumor about 1 cm at the sub-
phrenic area in the right lobe of liver was unexpected-
ly observed. There were neither symptoms nor signs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Photograph of resected specimen. The sec-
tion showed a dark-white, well-defined, 
non-encapsulated solid tumor with cirrho-
sis background 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Under high power field view, there are 
lymphocyte infiltrates within the LELC 
components (H&E, 100X magnification) 
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Figure 3. The immunostains of varies markers showed this intrahepatic lymphoepithelioma-like tumor was of 
biliary origin, and not originating from the liver. It showed negative AFP and HepPar-1 and positive 
stain of cytokeratin 7. (A) H&E stain, 100X original magnification, (B) AFP stain, 100X original mag-
nification, (C) CK7 stain, 100X original magnification, (D) HepPar-1 stain, 100X original magnification 
 
 
of possible cancer such as abdominal pain, nausea, 
vomiting or feeling an abdominal mass at the right 
abdominal upper quadrant. The serum tumor marker 
levels were as shown, including alpha-fetoprotein 
(AFP) 4.42 ng/mL (normal range < 10 mg/mL), car-
cinoembryonic antigen (CEA) 0.56 ng/mL (normal 
range < 5.00 ng/mL), and CA 19-9 8.82 U/mL (normal 
range < 37.00 U/mL). It was observed that those lev-
els were all within normal range. The liver multiphase 
computed tomography exam showed a nodular lesion 
at the hepatic dome of the right lobe of liver which 
was missed in the post contrast arterial phase due to 
the patient’s breathing depth, with contrast washout 
appearing in the venous and delayed phase. Due to the 
patient’s concerns about hepatoma, she then received 
liver segmentectomy. A 4.8 x 3.2 x 2.3 cm liver tissue 
was resected, revealing a solitary tumor with 1.7 cm in 
its greatest dimension. Microscopically, the tumor 
showed poor differentiated feature with focal glan-
dular pattern (Figure 1). This tumor also showed   
lymphoepithelioma-like features in most areas, and 
fibrous stroma with dense lymphocytic infiltrates  
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Figure 4. Tumor cells showed negative for Epstein- 
Barr virus by immunohistochemistry stain 
(200X original magnification) 
 
 
(Figure 2). It also showed immunoactivity for cy-
tokeratin 7 (CK-7) but without immunoactivity for 
AFP or Hep Par -1 u (Figure 3). The non-neoplastic 
liver showed cirrhosis with macro-nodular type ac-
cording to histology activity index. Additionally, the 
tumor exhibited no EBV infection by immunohisto-
chemistry staining targeting latent membrane protein 
(Figure 4). 
After that, the patient had regular follow-up at 
clinics and received abdominal ultrasound regularly as 
well. She was alive without disease and there was no 
tumor recurrence 3 years post surgery. 
 
DISCUSSION 
In this case report, we presented a patient with 
underlying cirrhosis, and chronic hepatitis C related to 
intrahepatic LELCC without association of EBV in-
fection. Concerning metastatic cancer, lymphoepithe-
lioma-like hepatocellular carcinoma and LELCC, an 
extensive clinical and radiological evaluation was 
done and showed no primary tumor at other sites, 
suggestive of tumor with the liver origin. The tissue 
immunostaining showed positive bile duct marker 
such as CK-7, but negative for hepatocyte markers 
such as AFP and Hep Par1-u, which would appear to 
be contrary to the diagnosis of lymphoepithelioma- 
like hepatocellular carcinoma.   
According to prior case reports, patients presented 
symptoms such as epigastric mass, abdominal fullness 
or vague epigastric pain. Most of the liver masses 
were found incidentally by abdominal ultrasonogra-
phy [4]. In our case, the liver tumor was found acci-
dently without EBV association. According to previ-
ous reports, marked female predominance is observed 
in EBV-associated LELCC and male predominance is 
found in non-EBV associated LELCC [2]. It has been 
reported that hepatitis B and hepatitis C infection are 
associated with an increased risk of intrahepatic chol-
angiocarcinoma [5]. Among those patients with EBV- 
negative LELCC, hepatitis B virus cirrhosis or hepati-
tis C virus cirrhosis might be related to the pathogene-
sis of LELCC. However, such speculation requires 
further study to confirm the hypothesis [6]. Various 
presentations including non-painful vague abdominal 
mass, dyspepsia, biliary colic and even incidental 
findings were found among EBV-associated LELCC 
[2]. According to one prior case report, LELCC not 
associated with EBV was an incidentally found tumor 
[6]. The prognosis of LELCC with EBV with and 
without infection was still uncertain due to the limited 
number of published cases to date [2].  
We followed-up this patient for 3 years and no-
ticed she was free from tumor recurrence. Prior re-
ports showed that the prognosis of LELCC is better 
than that of patients with ordinary cholangiocarcinoma. 
Along with this case, 16 out of 24 (66.7%) patients 
were alive without disease when the study and fol-
low-up were concluded. The poor prognosis might be 
related to lymph node metastasis and recurrent tumor 
[4]. However, there is minimal information available 
due to the limited number of reported cases [6]. 
Our study did have limitations. Primarily, we used 
immunohistochemistry stain associated with latent 
membrane protein to identify if EBV infection was in 
the tumor tissue. However, in order to potentially have 
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an elevated detection rate, other methods could be 
considered for evaluation such as Epstein-Barr vi-
rus-encoded small RNA in situ hybridization, or real 
time Epstein-Barr virus polymerase chain reaction. 
In summary, LELCC is a rare case variant of in-
trahepatic cholangiocarcinoma. Follow-up of this pa-
tient is important in an ongoing effort for clinicians to 
be able to utilize improved methods for early detection 
of metastatic diseases. Additionally, such follow-up 
could further help to elucidate the pathogenesis of 
hepatitis C virus-related LCLCC. 
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